Anesthesia during uterine curettage is a problem. Paracervical block is used in general for such an operation, though, the anesthetic efficacy is incomplete. Propofol is the short-lasting intravenous anesthetic administrated popularly. Sevoflurane is a new inhalational anesthetic well-known for it's "easy come, easy go" property. The investigators hypothesized that propofol, sevoflurane and paracervical block had different anesthetic efficacy during uterine curettage. Which one is the optimal selection for such operation needed to be evaluated.

Propofol 3mg/kg will be injected intravenously; 1 mg/kg will be added additionally for incomplete anesthesia

Other Name: Diprivan

Experimental: 3

Sevoflurane anesthesia will be performed

Drug: Sevoflurane

Sevoflurane 8% for anesthesia induction, 2-3% as the maintenance

Other Name: Sevorane

Eligibility

Ages Eligible for Study:

19 Years to 45 Years

Genders Eligible for Study:

Female

Accepts Healthy Volunteers:

No

Criteria

Inclusion Criteria:

ASA status I-II

Performing abortion operation (medical- or surgical)

Requiring painless abortion

Exclusion Criteria:

< 19 yrs, and >=45 yrs

History of central active drugs administration

Drug abuse

Hypertension

Diabetes

Any other chronic diseases

Allergy to the study drugs

Habit of over-volume alcohol drinking

Records of history of centrally active drug use and psychiatry

Any organic disorder

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00733564